Key Points - Revenue rose 3.0 % year over year to $10.85 billion, surpassing analyst expectations.- Non-GAAP earnings per ...

Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating ...

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, ...

Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...

Q2 2025 Management View CEO Marc N. Casper highlighted "excellent operational performance in the quarter, reflecting active management of our company and the strength of our proven growth strategy and ...

Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing expectations.

Thermo Fisher said on Wednesday the tariff situation was improving and raised the lower end of its annual profit forecast on ...

Thermo Fisher on Wednesday raised the lower end of its annual profit forecast, banking on strong demand for its tools and ...

Thermo Fisher Scientific (NYSE:TMO) stock gains as company beats Q2 2025 forecasts with $10.9B revenue, driven by Life ...

Thermo Fisher updated its full-year adjusted EPS to a range of $22.22 to $22.84 from the previous outlook of $21.76 to $22.84 ...

This was the stock's second consecutive day of gains.

Thermo Fisher Scientific posted better-than-expected profit and revenue in its latest quarter.